Skip to main content
S&P 5007,688.62+1.58%DOW53,356.12+3.03%NASDAQ25,736.51+1.44%BTC$80,787.00+5.07%ETH$2,431.65+7.47%GOLD$4,134.30+1.51%OIL$87.17-1.08%
Smart Investors Daily
SID Premium
CE

NASDAQ · CELZ

Creative Medical Technology Holdings, Inc.

Healthcare · Biotechnology

$0.65

Down-$0.02 (-3.21%)

Updated Nov 5, 2026, 8:24 AM

SID Score

3.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
5.75M
P/E ratio
-1
Dividend yield
0.00%
52-week range
$0.60 – $4.72
Volume
58.83K
Avg. volume
99.26K

Price performance · CELZ

CELZ price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 4, 2026

CELZ closed at $0.65 after 21 trading sessions, down 26.67% for the selected period.

Last close
$0.65
Period change
-26.67%
Period low
$0.62
Period high
$0.89
Daily close
View OHLC price history
CELZ OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 4, 2026$0.6737$0.7066$0.6221$0.651958.83K
Nov 3, 2026$0.645$0.6736$0.63$0.6735116.53K
Nov 2, 2026$0.6502$0.6737$0.6006$0.6235224.68K
Oct 30, 2026$0.719$0.719$0.6541$0.65587.32K
Oct 29, 2026$0.7225$0.7376$0.675$0.678462.65K
Oct 28, 2026$0.6925$0.7249$0.6717$0.7290.69K
Oct 27, 2026$0.7348$0.7383$0.681$0.6902142.13K
Oct 26, 2026$0.7651$0.7655$0.71$0.71244.9K
Oct 23, 2026$0.7651$0.7679$0.7311$0.7424.52K
Oct 22, 2026$0.7535$0.7798$0.7401$0.77454.09K
Oct 21, 2026$0.75$0.7646$0.73$0.742450.76K
Oct 20, 2026$0.702$0.78$0.68$0.7547413.37K
Oct 19, 2026$0.7474$0.7474$0.7222$0.723695.68K
Oct 16, 2026$0.839$0.8493$0.734$0.741172.96K
Oct 15, 2026$0.7799$0.8206$0.7628$0.817863.12K
Oct 14, 2026$0.80$0.80$0.7571$0.7723167.47K
Oct 13, 2026$0.83$0.85$0.81$0.819956.88K
Oct 12, 2026$0.83$0.8685$0.822$0.84190.21K
Oct 9, 2026$0.8602$0.88$0.82$0.8385149.37K
Oct 8, 2026$0.88$0.893$0.8601$0.860441.28K
Oct 7, 2026$0.91$0.91$0.8801$0.88952.22K

Latest CELZ news

The latest Smart Investors Daily articles mentioning CELZ.

Stock researchCompany · Overview

CELZ research

Overview

Company profile and research snapshot.

Company profile

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
CELZ recent ratings
DateFirmRatingTarget
Feb 25, 2022Roth CapitalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 20, 2026

Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study

International Scientific Presentation Underscores Encouraging Clinical Outcomes and Additional Biological Potency Findings Supporting Cell-Free Regenerative PlatformPHOENIX, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) ("Creative Medical" or the "Company"), a clinical-stage biotechnology company advancing regenerative medicine technologies, today highlighted additional clinical and laboratory findings for Ultrasome™, its investigational cell-free re

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By